Molecular laboratories are specialized environments equipped with cutting-edge instruments, reagents, and consumables designed to analyze DNA, RNA, and proteins at the molecular level. Central to modern genomics and diagnostics, these labs leverage technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), digital PCR, and CRISPR-based assays to deliver unprecedented precision in biological research, clinical diagnostics, food safety testing, environmental monitoring, and pharmaceutical development. As global demand for rapid, accurate, and scalable genomic analysis grows, molecular labs have become indispensable pillars of 21st-century science and industry.
High-throughput extraction, quantification, and sequencing workflows for research and clinical genomics.
Quantitative gene expression analysis with fluorescence detection for ultra-sensitive pathogen and biomarker identification.
Absolute quantification of nucleic acids with partition-based technology — ideal for rare mutation detection and liquid biopsy.
Machine learning algorithms integrated into modern PCR platforms accelerate result analysis and reduce human error.
Our flagship molecular lab instruments are engineered for precision, throughput, and reliability — trusted by leading research institutions and diagnostic laboratories worldwide.

High-speed gradient thermal cycling for precise DNA amplification in genomic research workflows.
Learn More
Multi-channel fluorescence detection for quantitative gene expression and pathogen load analysis.
Learn More
Fully automated, high-throughput DNA/RNA extraction from diverse biological sample types.
Learn More
Partition-based absolute quantification for rare variant detection and copy number variation analysis.
Learn MoreThe global molecular diagnostics and genomics market is experiencing explosive growth, projected to surpass USD 45 billion by 2030 at a CAGR exceeding 8.5%. PCR-based technologies alone account for over 35% of total molecular diagnostics revenue. Key drivers include the surge in infectious disease surveillance post-pandemic, rapid adoption of precision oncology, and expanding applications in agricultural genomics and food authenticity testing. Industrial end-users — from pharmaceutical manufacturers to forensic laboratories — are increasingly investing in integrated molecular lab platforms that combine automation, connectivity, and AI-powered analytics.
PCR and NGS-based liquid biopsy platforms are revolutionizing early cancer detection. Circulating tumor DNA (ctDNA) analysis via digital PCR enables non-invasive, real-time monitoring of tumor burden and treatment response, driving massive commercial investment from oncology-focused biotech firms.
Molecular labs are now embedded in food manufacturing and agri-genomics supply chains. PCR-based GMO detection, allergen screening, and species authentication are regulatory requirements in the EU, USA, and China, creating a rapidly growing industrial demand for high-throughput genomic testing solutions.
Biopharmaceutical manufacturers rely on molecular labs for cell line characterization, mycoplasma testing, viral clearance validation, and batch release PCR testing — all governed by FDA 21 CFR Part 11 and ICH Q5A guidelines, demanding validated, audit-ready instrument platforms.
Environmental DNA (eDNA) analysis using PCR is transforming biodiversity monitoring, water quality testing, and forensic investigations. Government agencies and environmental consultancies are deploying portable PCR systems for field-deployable genomic surveillance at scale.
The integration of robotic liquid handling, LIMS connectivity, and AI-driven data interpretation is reshaping molecular lab workflows. Smart PCR platforms with cloud-based result management and predictive maintenance are becoming the standard for high-volume clinical and industrial labs.
Miniaturized PCR platforms and isothermal amplification technologies are enabling molecular diagnostics at the point of care — in clinics, airports, and remote field sites — expanding the addressable market far beyond traditional centralized laboratory settings.
Since its invention by Kary Mullis in 1983, PCR has evolved from a research curiosity into the backbone of global molecular diagnostics. Today, real-time PCR, multiplex PCR, digital PCR, and isothermal PCR variants power everything from SARS-CoV-2 detection to whole-genome amplification. Its unmatched sensitivity (detecting as few as 1–10 copies of target DNA), specificity, speed, and scalability make PCR the irreplaceable foundation of every modern molecular lab — and the primary driver of genomic analysis instrument demand worldwide.
From hospital diagnostics to industrial quality control, molecular labs powered by PCR and genomic analysis technologies are transforming how industries detect, quantify, and interpret biological information.
PCR-based assays for infectious disease (TB, HIV, HPV, respiratory pathogens), genetic disease screening, and pharmacogenomics guide clinical decision-making in hospitals and reference labs.
Universities and research institutes use qPCR, NGS, and CRISPR screening workflows for gene expression studies, epigenomics, and functional genomics — fueled by government and private research funding.
Molecular labs in pharma R&D enable target identification, biomarker validation, companion diagnostic development, and GMP-compliant batch testing for biologic drug products.
PCR-based seed purity testing, disease resistance genotyping, and GMO trait verification are critical quality control steps for seed companies and agricultural biotechnology firms.
Real-time PCR enables rapid detection of foodborne pathogens (Salmonella, Listeria, E. coli O157), allergens, and species adulteration — meeting FSMA, EU Regulation 1169/2011, and HACCP requirements.
PCR diagnostics for animal infectious diseases (PRRS, FMD, ASF, avian influenza) support livestock biosecurity programs and international trade compliance in the animal health industry.
eDNA-based PCR assays detect invasive species, monitor microbial communities in water systems, and support biodiversity assessments — increasingly mandated by environmental regulatory agencies.
STR-based PCR profiling, mitochondrial DNA analysis, and Y-chromosome typing are foundational forensic genomics techniques used in criminal investigations, paternity testing, and disaster victim identification.
Explore our comprehensive portfolio of PCR instruments, nucleic acid extraction systems, genomic reagents, and laboratory consumables — designed to support every stage of your genomic analysis pipeline.

Automated high-throughput DNA/RNA isolation from blood, tissue & swabs.
Details
Absolute quantification for rare mutation & copy number variation analysis.
Details
Optimized master mixes for high-fidelity PCR, RT-PCR, and multiplex assays.
Details
DNA fragment separation and visualization for PCR product analysis and genotyping.
Details
UV-Vis absorbance and fluorescence measurement for nucleic acid quantification.
Details
RNase/DNase-free plates, tubes, and sealing films for contamination-free PCR workflows.
DetailsOur molecular lab instruments and genomic analysis solutions have earned recognition from leading international certification bodies and industry organizations — reflecting our unwavering commitment to quality, safety, and scientific excellence.











